Answers are grounded in this paper and cite their sources.
Permeability is a key physicochemical property in identifying promising candidates in early drug discovery. Previous efforts were reported to correlate cell permeability with exposed polar surface area (EPSA) and Immobilized Artificial Membrane chromatography (IAM) as separate parameters. We report a multiparameter descriptor, normalized EPSA (nEPSA), which combines contributions from the IMHB identified in the EPSA assay and cell membrane interactions in the IAM assay. Furthermore, the application of this descriptor revealed distinct physicochemical space associated with highly cell permeable molecules. This optimal space was observed across small molecules in both passive (ALogP 2.5-3.9; nEPSA 2.0-3.2) and transporter mediated (ALogP 2.6 - 4.1; nEPSA 1.4-2.0) permeability assays, as well as for beyond Rule of 5 (bRo5) molecules (ALogP 2.7-4.0; nEPSA 1.5-2.0). Our observations demonstrate that nEPSA provides a robust guideline for navigating permeable space in candidate optimization.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: